Rami Abuqubo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Rami Abuqubo has a total of 55 co-authors. Here are the top co-authors by number of shared publications:
- Mitchell Stephen Fourman
Montefiore Medical Center
4 shared publications - Ananth Eleswarapu
Department of Orthopedic Surgery, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, USA
3 shared publications - Noel Osereimen Akioyamen
Department of Orthopedic Surgery Montefiore Medical Center Bronx New York U.S.A.
3 shared publications - Rafael De la Garza Ramos
Department of Neurological Surgery, Montefiore Medical Center, Albert Einstein College of Medicine, New York, NY
3 shared publications - Abhinav Suri
Department of Radiology, David Geffen School of Medicine at UCLA, Los Angeles, Calif
2 shared publications - Alexander Yu
Department of Orthopaedic Surgery, Icahn School of Medicine at Mount Sinai, New York, NY, USA
2 shared publications
Latest Publications
- Open Access
- 4 December 2025
- Published by Elsevier in World Neurosurgery
- Vol. 205, 124709
Prognostic Performance of mFI-5 and mFI-11 Frailty Indices in Elective Spine Surgery: A Systematic Review and Meta-Analysis
- 4 December 2025
- Published by Elsevier in World Neurosurgery
- Vol. 205, 124709
Open AccessPrognostic Performance of mFI-5 and mFI-11 Frailty Indices in Elective Spine Surgery: A Systematic Review and Meta-Analysis
- Open Access
- 4 December 2025
- Published by JMIR Publications Inc. in JMIR AI
- Vol. 4, e72535
The Perceived Roles of AI in Clinical Practice: National Survey of 941 Academic Physicians
Background: Artificial intelligence (AI) and machine learning models are frequently developed in medical research to optimize patient care, yet they remain rarely used in clinical practice. Objective: This study aims to understand the disconnect between model development and implementation by surveying physicians of all specialties across the United States. Methods: The present survey was distributed to residency coordinators at Accreditation Council for Graduate Medical Education–accredited residency programs to disseminate among attending physicians and resident physicians affiliated with their academic institution. Respondents were asked to identify and quantify the extent of their training and specialization, as well as the type and location of their practice. Physicians were then asked follow-up questions regarding AI in their practice, including whether its use is permitted, whether they would use it if made available, primary reasons for using or not using AI, elements that would encourage its use, and ethical concerns. Results: Of the 941 physicians who responded to the survey, 384 (40.8%) were attending physicians and 557 (59.2%) were resident physicians. The majority of the physicians (651/795, 81.9%) indicated that they would adopt AI in clinical practice if given the opportunity. The most cited intended uses for AI were risk stratification, image analysis or segmentation, and disease prognosis. The most common reservations were concerns about clinical errors made by AI and the potential to replicate human biases. Conclusions: To date, this study comprises the largest and most diverse dataset of physician perspectives on AI. Our results emphasize that most academic physicians in the United States are open to adopting AI in their clinical practice. However, for AI to become clinically relevant, developers and physicians must work synergistically to design models that are accurate, accessible, and intuitive while thoroughly addressing ethical concerns associated with the implementation of AI in medicine.
- 4 December 2025
- Published by JMIR Publications Inc. in JMIR AI
- Vol. 4, e72535
Open AccessThe Perceived Roles of AI in Clinical Practice: National Survey of 941 Academic Physicians
Background: Artificial intelligence (AI) and machine learning models are frequently developed in medical research to optimize patient care, yet they remain rarely used in clinical practice. Objective: This study aims to understand the disconnect between model development and implementation by surveying physicians of all specialties across the United States. Methods: The present survey was distributed to residency coordinators at Accreditation Council for Graduate Medical Education–accredited residency programs to disseminate among attending physicians and resident physicians affiliated with their academic institution. Respondents were asked to identify and quantify the extent of their training and specialization, as well as the type and location of their practice. Physicians were then asked follow-up questions regarding AI in their practice, including whether its use is permitted, whether they would use it if made available, primary reasons for using or not using AI, elements that would encourage its use, and ethical concerns. Results: Of the 941 physicians who responded to the survey, 384 (40.8%) were attending physicians and 557 (59.2%) were resident physicians. The majority of the physicians (651/795, 81.9%) indicated that they would adopt AI in clinical practice if given the opportunity. The most cited intended uses for AI were risk stratification, image analysis or segmentation, and disease prognosis. The most common reservations were concerns about clinical errors made by AI and the potential to replicate human biases. Conclusions: To date, this study comprises the largest and most diverse dataset of physician perspectives on AI. Our results emphasize that most academic physicians in the United States are open to adopting AI in their clinical practice. However, for AI to become clinically relevant, developers and physicians must work synergistically to design models that are accurate, accessible, and intuitive while thoroughly addressing ethical concerns associated with the implementation of AI in medicine.
- Open Access
- 3 October 2025
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 15 (10) , 480
Current Applications and Future Directions of Technologies Used in Adult Deformity Surgery for Personalized Alignment: A Narrative Review
Patient-specific technologies within the field of adult spinal deformity (ASD) aid surgeons in pre-surgical planning, accurately help identify anatomical landmarks, and can project optimal post-surgical sagittal alignment. This narrative review aims to discuss the current uses of patient-specific technologies in ASD and identify new innovations that may very soon be integrated into patient care. Pre-operatively, machine learning or artificial intelligence helps surgeons to simulate post-operative alignment and provide information for the 3D-printing of pre-contoured rods and patient-specific cages. Intraoperatively, robotic surgery and intraoperative guides allow for more accurate positioning of implants. Implant materials are being developed to allow for better osseointegration and patient outcome monitoring. Despite the significant promise of these technologies, work still needs to be performed to ensure their accuracy, safety, and cost efficacy.
- 3 October 2025
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 15 (10) , 480
Open AccessCurrent Applications and Future Directions of Technologies Used in Adult Deformity Surgery for Personalized Alignment: A Narrative Review
Patient-specific technologies within the field of adult spinal deformity (ASD) aid surgeons in pre-surgical planning, accurately help identify anatomical landmarks, and can project optimal post-surgical sagittal alignment. This narrative review aims to discuss the current uses of patient-specific technologies in ASD and identify new innovations that may very soon be integrated into patient care. Pre-operatively, machine learning or artificial intelligence helps surgeons to simulate post-operative alignment and provide information for the 3D-printing of pre-contoured rods and patient-specific cages. Intraoperatively, robotic surgery and intraoperative guides allow for more accurate positioning of implants. Implant materials are being developed to allow for better osseointegration and patient outcome monitoring. Despite the significant promise of these technologies, work still needs to be performed to ensure their accuracy, safety, and cost efficacy.
- 21 July 2025
- Published by Springer Nature in European Spine Journal
- p. 1-13
The characterization of frailty in spine surgery: a systematic review of frailty indices
Purpose Frailty is a key predictor of postoperative outcomes in spine surgery, yet its definition varies widely across studies. Most research relies on comorbidity-based indices like the modified frailty index (mFI), overlooking the multidimensional nature of frailty. The purpose of this systematic review is to identify the frailty indices in use, assess their prevalence, and evaluate their association with clinical outcomes. Methods Following PRISMA guidelines, a comprehensive search of PubMed, Scopus, and Web of Science identified 34 relevant cohort studies on elective spine procedures using frailty indices. Data were collected on frailty measures, complications, and perioperative events, including non-routine discharge, reoperation, readmission, and mortality. Results The mFI was the most used measure, with mFI-11 (38%) and mFI-5 (29%) being the most common. The Hospital Frailty Risk Score appeared in 9%, while the Adult Spinal Deformity Frailty Index and FRAIL were used in 6%. The Fried Frailty Index and Canadian Study of Health and Aging Clinical Frailty Scale were less frequent (3%). Sarcopenia was assessed in 12% of studies. Frailty was an independent variable in 94%, and complications were reported in 85%. Medical and surgical complications occurred in 67% and 62%, respectively; non-routine discharge in 47%, readmission in 29%, and mortality in 26%. Conclusion While mFI-5 and mFI-11 are commonly used, their comorbidity-based approach limits frailty assessment. Future research should prioritize multidimensional indices like the Fried Frailty Index and FRAIL scale, which incorporate functional measures for better risk stratification in spine surgery.
- 21 July 2025
- Published by Springer Nature in European Spine Journal
- p. 1-13
The characterization of frailty in spine surgery: a systematic review of frailty indices
Purpose Frailty is a key predictor of postoperative outcomes in spine surgery, yet its definition varies widely across studies. Most research relies on comorbidity-based indices like the modified frailty index (mFI), overlooking the multidimensional nature of frailty. The purpose of this systematic review is to identify the frailty indices in use, assess their prevalence, and evaluate their association with clinical outcomes. Methods Following PRISMA guidelines, a comprehensive search of PubMed, Scopus, and Web of Science identified 34 relevant cohort studies on elective spine procedures using frailty indices. Data were collected on frailty measures, complications, and perioperative events, including non-routine discharge, reoperation, readmission, and mortality. Results The mFI was the most used measure, with mFI-11 (38%) and mFI-5 (29%) being the most common. The Hospital Frailty Risk Score appeared in 9%, while the Adult Spinal Deformity Frailty Index and FRAIL were used in 6%. The Fried Frailty Index and Canadian Study of Health and Aging Clinical Frailty Scale were less frequent (3%). Sarcopenia was assessed in 12% of studies. Frailty was an independent variable in 94%, and complications were reported in 85%. Medical and surgical complications occurred in 67% and 62%, respectively; non-routine discharge in 47%, readmission in 29%, and mortality in 26%. Conclusion While mFI-5 and mFI-11 are commonly used, their comorbidity-based approach limits frailty assessment. Future research should prioritize multidimensional indices like the Fried Frailty Index and FRAIL scale, which incorporate functional measures for better risk stratification in spine surgery.
- Open Access
- 28 May 2025
- Published by Elsevier in JSES International
- Vol. 9 (5) , 1653-1659
Does computed tomography–based local soft tissue composition more accurately predict outcomes following anatomic total shoulder arthroplasty compared with body mass index?: a pilot study
- 28 May 2025
- Published by Elsevier in JSES International
- Vol. 9 (5) , 1653-1659
Open AccessDoes computed tomography–based local soft tissue composition more accurately predict outcomes following anatomic total shoulder arthroplasty compared with body mass index?: a pilot study
- Open Access
- 11 February 2025
- Published by JMIR Publications Inc. in JMIR Preprints
The Perceived Roles of AI in Clinical Practice: National Survey of 941 Academic Physicians (Preprint)
BACKGROUND Artificial intelligence (AI) and machine learning models are frequently developed in medical research to optimize patient care, yet they remain rarely used in clinical practice. OBJECTIVE This study aims to understand the disconnect between model development and implementation by surveying physicians of all specialties across the United States. METHODS The present survey was distributed to residency coordinators at Accreditation Council for Graduate Medical Education–accredited residency programs to disseminate among attending physicians and resident physicians affiliated with their academic institution. Respondents were asked to identify and quantify the extent of their training and specialization, as well as the type and location of their practice. Physicians were then asked follow-up questions regarding AI in their practice, including whether its use is permitted, whether they would use it if made available, primary reasons for using or not using AI, elements that would encourage its use, and ethical concerns. RESULTS Of the 941 physicians who responded to the survey, 384 (40.8%) were attending physicians and 557 (59.2%) were resident physicians. The majority of the physicians (651/795, 81.9%) indicated that they would adopt AI in clinical practice if given the opportunity. The most cited intended uses for AI were risk stratification, image analysis or segmentation, and disease prognosis. The most common reservations were concerns about clinical errors made by AI and the potential to replicate human biases. CONCLUSIONS To date, this study comprises the largest and most diverse dataset of physician perspectives on AI. Our results emphasize that most academic physicians in the United States are open to adopting AI in their clinical practice. However, for AI to become clinically relevant, developers and physicians must work synergistically to design models that are accurate, accessible, and intuitive while thoroughly addressing ethical concerns associated with the implementation of AI in medicine. CLINICALTRIAL
- 11 February 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessThe Perceived Roles of AI in Clinical Practice: National Survey of 941 Academic Physicians (Preprint)
BACKGROUND Artificial intelligence (AI) and machine learning models are frequently developed in medical research to optimize patient care, yet they remain rarely used in clinical practice. OBJECTIVE This study aims to understand the disconnect between model development and implementation by surveying physicians of all specialties across the United States. METHODS The present survey was distributed to residency coordinators at Accreditation Council for Graduate Medical Education–accredited residency programs to disseminate among attending physicians and resident physicians affiliated with their academic institution. Respondents were asked to identify and quantify the extent of their training and specialization, as well as the type and location of their practice. Physicians were then asked follow-up questions regarding AI in their practice, including whether its use is permitted, whether they would use it if made available, primary reasons for using or not using AI, elements that would encourage its use, and ethical concerns. RESULTS Of the 941 physicians who responded to the survey, 384 (40.8%) were attending physicians and 557 (59.2%) were resident physicians. The majority of the physicians (651/795, 81.9%) indicated that they would adopt AI in clinical practice if given the opportunity. The most cited intended uses for AI were risk stratification, image analysis or segmentation, and disease prognosis. The most common reservations were concerns about clinical errors made by AI and the potential to replicate human biases. CONCLUSIONS To date, this study comprises the largest and most diverse dataset of physician perspectives on AI. Our results emphasize that most academic physicians in the United States are open to adopting AI in their clinical practice. However, for AI to become clinically relevant, developers and physicians must work synergistically to design models that are accurate, accessible, and intuitive while thoroughly addressing ethical concerns associated with the implementation of AI in medicine. CLINICALTRIAL
- Open Access
- 24 September 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (19) , 5679
Immunologic and Targeted Molecular Therapies for Chordomas: A Narrative Review
Chordomas are rare sarcomas arising from notochordal tissue and occur most commonly in the spine. The standard of care for chordomas without evidence of metastatic disease generally consists of en bloc resection followed by adjuvant radiotherapy. However, long-term (20-year) survival rates are approximately 30%. Chordomas are generally considered as chemo resistant. Therefore, systemic therapies have rarely been employed. Novel immunotherapies, including antibody therapy and tumor vaccines, have shown promise in early trials, leading to extended progression-free survival and symptom relief. However, the outcomes of larger trials using these vectors are heterogeneous. The aim of this review is to summarize novel chordoma treatments in immune-targeted therapies. The current merits, trial outcomes, and toxicities of these novel immune and targeted therapies, including those targeting vascular endothelial growth factor receptor (VEGFR) targets and the epidermal growth factor receptor (EGFR), will be discussed.
- 24 September 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (19) , 5679
Open AccessImmunologic and Targeted Molecular Therapies for Chordomas: A Narrative Review
Chordomas are rare sarcomas arising from notochordal tissue and occur most commonly in the spine. The standard of care for chordomas without evidence of metastatic disease generally consists of en bloc resection followed by adjuvant radiotherapy. However, long-term (20-year) survival rates are approximately 30%. Chordomas are generally considered as chemo resistant. Therefore, systemic therapies have rarely been employed. Novel immunotherapies, including antibody therapy and tumor vaccines, have shown promise in early trials, leading to extended progression-free survival and symptom relief. However, the outcomes of larger trials using these vectors are heterogeneous. The aim of this review is to summarize novel chordoma treatments in immune-targeted therapies. The current merits, trial outcomes, and toxicities of these novel immune and targeted therapies, including those targeting vascular endothelial growth factor receptor (VEGFR) targets and the epidermal growth factor receptor (EGFR), will be discussed.